Segment, Customer and Geographical Reporting (Details) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Sep. 30, 2013
Segment Reporting Information [Line Items]
Revenue	$ 10,406,458	$ 10,484,530	$ 21,117,986	$ 21,037,805
Gross Profit	4,358,887	4,641,513	8,809,415	9,147,767
Impairment of goodwill	0	6,763,072	0	6,763,072
Operating Income (Loss)	467,227	(7,248,014)	2,081,444	(7,439,301)
Depreciation and Amortization	268,448	443,717	534,773	870,175
Capital expenditures	408,558	(99,889)	539,476	215,679
Intangibles, Net	1,321,561	3,776,038	1,321,561	3,776,038	3,484,583
Goodwill	6,272,228	6,135,642	6,272,228	6,135,642	6,240,983
Total Assets	24,833,473	28,278,468	24,833,473	28,278,468	26,677,226
Contract Research [Member]
Segment Reporting Information [Line Items]
Revenue	5,614,060	5,487,850	11,454,502	10,398,690
Gross Profit	2,441,719	2,647,870	4,971,257	4,861,923
Impairment of goodwill	0	0	0	0
Operating Income (Loss)	241,938	232,015	590,332	231,409
Depreciation and Amortization	69,949	79,637	139,496	142,419
Capital expenditures	12,028	(187,425)	12,028	(1,095)
Intangibles, Net	315,651	349,786	315,651	349,786
Goodwill	4,938,625	4,938,625	4,938,625	4,938,625
Total Assets	10,230,207	13,332,151	10,230,207	13,332,151
Optics [Member]
Segment Reporting Information [Line Items]
Revenue	4,788,669	3,931,766	8,887,177	8,183,706
Gross Profit	1,919,261	1,481,948	3,516,521	3,061,891
Impairment of goodwill	0	0	0	0
Operating Income (Loss)	522,112	2,336	920,544	388,012
Depreciation and Amortization	183,499	184,696	361,607	370,324
Capital expenditures	396,530	87,536	527,448	209,682
Intangibles, Net	857,579	866,488	857,579	866,488
Goodwill	1,333,603	1,197,017	1,333,603	1,197,017
Total Assets	13,815,832	9,748,703	13,815,832	9,748,703
Instruments [Member]
Segment Reporting Information [Line Items]
Revenue	0	1,014,320	772,578	2,298,358
Gross Profit	(5,822)	461,101	317,908	1,066,902
Impairment of goodwill	0	6,763,072	0	6,763,072
Operating Income (Loss)	(75,585)	(7,270,801)	966,178	(7,726,495)
Depreciation and Amortization	0	164,384	2,003	327,432
Capital expenditures	0	0	0	7,092
Intangibles, Net	0	2,349,767	0	2,349,767
Goodwill	0	0	0	0
Total Assets	455,096	4,862,956	455,096	4,862,956
Biomedical [Member]
Segment Reporting Information [Line Items]
Revenue	3,729	50,594	3,729	157,051
Gross Profit	3,729	50,594	3,729	157,051
Impairment of goodwill	0	0	0	0
Operating Income (Loss)	(221,238)	(211,564)	(395,610)	(332,227)
Depreciation and Amortization	15,000	15,000	31,667	30,000
Capital expenditures	0	0	0	0
Intangibles, Net	148,331	209,997	148,331	209,997
Goodwill	0	0	0	0
Total Assets	$ 332,338	$ 334,658	$ 332,338	$ 334,658